1. KRAS Mutations and Primary Resistance of Lung Adencarcinomas to Gefitnib or Erlotinib Publication: Public Library of Science, January 2005 Subject(s): MutationLung Neoplasms Archival Collection: The Harold Varmus Papers (Profiles in Science)
